학술논문
A phase 1 trial of human telomerase reverse transcriptase (hTERT) vaccination combined with therapeutic strategies to control immune-suppressor mechanisms.
Document Type
Article
Author
Source
Experimental Biology & Medicine; 2024, p1-11, 11p
Subject
Language
ISSN
15353702